Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. Net Income for the year ending August 31, 2024: USD 4.77 M

Cannara Biotech Inc. Net Income is USD 4.77 M for the year ending August 31, 2024, a -7.13% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Cannara Biotech Inc. Net Income for the year ending August 31, 2023 was USD 5.14 M, a 192.81% change year over year.
  • Cannara Biotech Inc. Net Income for the year ending August 31, 2022 was USD 1.75 M, a 171.54% change year over year.
  • Cannara Biotech Inc. Net Income for the year ending August 31, 2021 was USD -2.45 M, a 76.82% change year over year.
  • Cannara Biotech Inc. Net Income for the year ending August 31, 2020 was USD -10.58 M, a -2.29% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 7, 2025

Any question? Send us an email